share_log

羚锐制药(600285.SH):减持实施完毕 新锐投资累计减持1.92%公司股份

Ling Rui Pharmaceutical (600285.SH): After implementing the holdings reduction, Xinrui Investment reduced its holdings by 1.92% of the company's shares

Gelonghui Finance ·  May 14 06:42

Gelonghui, May 14, 丨 Ling Rui Pharmaceutical (600285.SH) announced that recently, the company received a “Notice of Shareholding Reduction Results” from Xinrui Investment. As of May 14, 2024, Xinrui Investment had reduced its holdings of the company's shares by 10.867 million shares through bulk transactions, accounting for 1.92% of the company's total share capital before the implementation of the holdings reduction plan. The implementation of this holdings reduction plan was completed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment